← 返回

间充质干细胞介导治疗脑肿瘤的分子机制与通路

英文原题:Molecular Mechanisms and Pathways of Mesenchymal Stem Cell-mediated Therapy in Brain Cancer.

查看英文原题

Molecular Mechanisms and Pathways of Mesenchymal Stem Cell-mediated Therapy in Brain Cancer.

PubMed 2025/01/01(内容时间) Curr Stem Cell Res Ther Q4 · IF 2.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

间充质干细胞(MSCs)因其独特的生物学特性,包括归巢至肿瘤部位、调节肿瘤微环境以及发挥抗肿瘤效应的能力,已成为治疗脑癌的一种有前景的治疗手段。本综述深入探讨了MSCs介导的脑癌治疗所涉及的分子机制和通路。我们探索了MSCs激活的、有助于其治疗功效的各种信号通路,例如PI3K/Akt、Wnt/-catenin和Notch通路。此外,我们还讨论了MSCs分泌的外泌体和microRNAs在介导抗肿瘤效应中的作用。本综述还阐述了优化基于MSCs的脑癌治疗所面临的挑战和未来方向,包括与MSC来源、递送方法和潜在副作用相关的问题。通过对这些机制和通路的全面理解,我们旨在强调MSCs作为脑癌可行治疗选择的潜力,并为该领域的未来研究提供指导。

展开英文摘要原文

Mesenchymal stem cells (MSCs) have emerged as a promising therapeutic approach in the treatment of brain cancer due to their unique biological properties, including their ability to home tumor sites, modulate the tumor microenvironment, and exert anti-tumor effects. This review delves into the molecular mechanisms and pathways underlying MSC-mediated therapy in brain cancer.

We explore the various signalling pathways activated by MSCs that contribute to their therapeutic efficacy, such as the PI3K/Akt, Wnt/ -catenin, and Notch pathways.

Additionally, we discuss the role of exosomes and microRNAs secreted by MSCs in mediating anti-tumor effects. The review also addresses the challenges and future directions in optimizing MSC-based therapies for brain cancer, including issues related to MSC sourcing, delivery methods, and potential side effects. Through a comprehensive understanding of these mechanisms and pathways, we aim to highlight the potential of MSCs as a viable therapeutic option for brain cancer and to guide future research in this field.

论文信息

作者
Singh K、Singh G、Gupta JK、Choudhary AN、Kumar A、Jain D、Sharma MC、Kumar S
单位
Department of Pharmacology, Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India.India
文献类型
综述
期刊
Current stem cell research & therapy2025
原文标识
PubMed 39851121 · DOI 10.2174/011574888X341525250116052000